We recently reported that inhibition of NF-kB activation as a consequence of the overexpression of a degradationresistant form of IkBa [IkBa(A32/36)] sensitized Ewing sarcoma cells to TNFa-induced killing. The c-Jun Nterminal kinases (JNK) have been shown to participate in death signaling triggered by certain stimuli and are activated by TNFa. To obtain insight into the mechanism of the anti-apoptotic eect of NF-kB, we compared the pro®les of JNK activation by TNFa in control cells and in cells in which NF-kB activation was impaired. We show here that JNK activation was transient in control cells but remained elevated in IkBa(A32/36)-expressing cells. NF-kB repressed speci®cally the JNK pathway, since the kinetics of activation of the other TNFaactivated-MAP kinase p38 were identical in both cells. Prolongation of JNK activation in IkBa(A32/36)-expressing cells was not inhibited by the broad spectrum caspase inhibitor Z-VAD-FMK and thus was not the consequence of caspase activation. Pretreatment of control cells with the phosphatase inhibitor vanadate greatly prolonged JNK activation by TNFa and resulted in induction of apoptosis by this cytokine. Moreover, overexpression of a dominant-negative mutant of JNK1 decreased TNFa-induced apoptosis in cells expressing the super repressor of NF-kB, indicating that the sustained activation of JNK1 participated in death signaling triggered by TNFa. Our results provide evidence that the repression of JNK activation by NF-kB participates in the anti-apoptotic eect of this transcription factor in TNFa-treated Ewing sarcoma cells. Oncogene (2001) 20, 4365 ± 4372.
We recently reported that inhibition of NF-kB activation as a consequence of the overexpression of a degradationresistant form of IkBa [IkBa(A32/36)] sensitized Ewing sarcoma cells to TNFa-induced killing. The c-Jun Nterminal kinases (JNK) have been shown to participate in death signaling triggered by certain stimuli and are activated by TNFa. To obtain insight into the mechanism of the anti-apoptotic eect of NF-kB, we compared the pro®les of JNK activation by TNFa in control cells and in cells in which NF-kB activation was impaired. We show here that JNK activation was transient in control cells but remained elevated in IkBa(A32/36)-expressing cells. NF-kB repressed speci®cally the JNK pathway, since the kinetics of activation of the other TNFaactivated-MAP kinase p38 were identical in both cells. Prolongation of JNK activation in IkBa(A32/36)-expressing cells was not inhibited by the broad spectrum caspase inhibitor Z-VAD-FMK and thus was not the consequence of caspase activation. Pretreatment of control cells with the phosphatase inhibitor vanadate greatly prolonged JNK activation by TNFa and resulted in induction of apoptosis by this cytokine. Moreover, overexpression of a dominant-negative mutant of JNK1 decreased TNFa-induced apoptosis in cells expressing the super repressor of NF-kB, indicating that the sustained activation of JNK1 participated in death signaling triggered by TNFa. Our results provide evidence that the repression of JNK activation by NF-kB participates
Introduction
Tumor Necrosis Factor (TNFa) is a cytokine that causes a wide range of cellular responses, like apoptosis, proliferation, dierentiation, in¯ammation and chemotaxis (Tracey and Cerami, 1994) . The pleiotropic eects of TNFa are a consequence of its ability to trigger several signaling pathways, the relative intensity of which may vary with cell type and cellular context. TNFa binds to two ubiquitous receptors, TNF receptor I (TNFRI) and TNF receptor II (TNFRII) (Tartaglia and Goeddel, 1992; Smith et al., 1994) . TNFa binding induces receptor oligomerization which results in the recruitment of a number of cytoplasmic signaling proteins (Ashkenazi and Dixit, 1998; Baker and Reddy, 1998; Yeh et al., 1999) . TNFRI interacts via TRADD with the cytoplasmic adaptor protein FADD, which recruits caspase-8, a key initiator of apoptosis signaling (Yeh et al., 1999) . In response to TNFa, TNFRI and TNFRII also associate directly or indirectly with RIP and TRAF2 proteins which mediate rapid activation of the transcription factor NF-kB and of the mitogen activated protein (MAP) kinases, p46/p54 c-Jun N terminal kinase (JNK) and p38 kinase (Baeuerle and Baltimore, 1996; Minden et al., 1994; Raingeaud et al., 1995) .
Originally described as regulators of immune and in¯ammatory responses, the NF-kB family of transcription factors was subsequently shown to play a more general role in cell proliferation and dierentiation and has been associated with several malignancies Gerondakis et al., 1999; Rayet and Gelinas, 1999) . Recently, evidence for a role of NF-kB in the regulation of apoptosis has also accumulated (Barkett and Gilmore, 1999) . Although activation of NF-kB can promote apoptosis in some cells, it has been associated more commonly with a decrease in the susceptibility of many cell types to apoptotic stimuli. Inactivation of the TNFa-inducible NF-kB pathway potentiates the cytotoxic action of TNFa or genotoxic agents and can render cells resistant to TNFa sensitive to this reagent (Beg and Baltimore, 1996; Liu et al., 1996; Van Antwerp et al., 1996; Wang et al., 1996) . Similarly, we have observed that Ewing sarcoma cells that are resistant to TNFa-induced apoptosis acquire susceptibility to this cytokine, when transfected with a vector encoding a super repressor of NF-kB (Javelaud et al., 2000) .
JNK and p38 MAP kinases are predominantly activated by in¯ammatory cytokines and stress stimuli. Upon activation, these kinases translocate to the nucleus, where they activate transcription factors by mediating their phosphorylation, ATF2, c-jun, and Elk-1 are activated by JNK, whereas ATF2, Elk-1 and MEF-2C are activated by p38 (Ip and Davis, 1998; Ichijo, 1999; Davis, 2000) . JNKs are activated by phosphorylation within kinase subdomain VIII on Tyr and Thr by the dual speci®city MAP kinase kinases (MAPKKs), MKK4/SEK1 and MKK7. The p38 kinases are similarly activated by MKK3 and MKK6/SAPKK3. Several upstream MAP kinase kinase kinases (MAPKKKs) can activate both the JNK and the p38 pathways. Among these MAPKKKs, apoptosis signal-regulating kinase 1 (ASK1) and MEKK1 were shown to be activated by TNFa (Ichijo, 1999) . Investigations of the link between activation of JNK and induction of apoptosis by TNFa have led to controversial results (Liu et al., 1996; Verheij et al., 1996; Cuvillier et al., 1996; Ichijo et al., 1997; Reinhard et al., 1997; Natoli et al., 1997; Lee et al., 1997; Yeh et al., 1997) . In fact, it emerges from several studies that it is the duration of JNK activation induced by TNFa or a variety of stresses that is a crucial determinant of the cell response (Chen et al., 1996; Guo et al., 1998; Sanchez-Perez et al., 1998) .
Here, we describe a novel eect of NF-kB activation in TNFa-treated cells. We show that whereas TNFa induced a transient JNK activation in control cells, this activation was sustained in cells expressing a super repressor of NF-kB activation. We also provide evidence that the repression of JNK activation by NF-kB participates in the anti-apoptotic eect of this transcription factor.
Results
Kinetics of JNK activation by TNFa in the presence or absence of a super repressor of NF-kB To investigate whether NF-kB activation in¯uences the kinetics of JNK activation by TNFa, the time dependence of this activation was compared in EW7pc control cells and EW7MAD cells that carry a super repressor of NF-kB. Cells were treated for dierent times with TNFa, and JNK activation was determined by Western blot analysis using antibodies that speci®cally recognized the phosphorylated forms of JNK. As shown in Figure 1a , two isoforms of JNK (46 kDa and 54 kDa) were present as it was previously described (Gupta et al., 1996) . The kinetics of JNK activation in EW7pc control cells were dierent from those observed in EW7MAD1 cells (Figure 1a) . In EW7pc cells, JNK activation was transient, maximal activation was reached within 15 min and returned to the basal level by 1 h. In contrast, in EW7MAD1 cells, JNK phosphorylation was sustained, since it was still present after 15 h. Hybridization of the blots with anti-JNK antibodies revealed that JNK activation occurred in the absence of any change in JNK expression (Figure 1a) . Such a sustained JNK activation was similarly observed upon treatment with TNFa of another clone of IkBa(A32/36)-carrying EW7 cells (EW7MAD2, not shown).
In another approach and to corroborate these ®ndings, JNK activation was determined in JNK1 immunoprecipitates by direct phosphorylation of recombinant c-jun. Results are presented in Figure  1b . Here again, TNFa stimulated a single transient JNK activity peak in EW7pc cells, whereas TNFainduced JNK activity was sustained in EW7MAD1 cells.
The time dependence of p21 waf1/cip1 induction does not correlate with that of JNK dephosphorylation in TNFa-treated EW7pc cells
We previously demonstrated that in TNFa-treated Ewing sarcoma cells NF-kB exerts part of its antiapoptotic eect through induction of p21 waf1/cip1 expression (Javelaud et al., 2000) . Since p21 waf1/cip1 can inhibit JNK activation (Shim et al., 1996; Patel et al., 1998; Asada et al., 1999) , we investigated whether the kinetics of p21 waf1/cip1 induction by TNFa correlated with that of the rapid JNK dephosphorylation observed in EW7pc cells. As shown in Figure 2 , Figure 1 Eect of NF-kB on the kinetics of JNK activation by TNFa. (a) EW7pc or EW7MAD1 cells were treated with TNFa for indicated times followed by cell lysis. Equal amounts of proteins were analysed by Western blot using polyclonal antiphospho-JNK antibodies (top). The blots were stripped and reprobed with an antibody to JNK1 (bottom). (b) Cell lysates were immunoprecipitated with goat anti-JNK1 antibodies, and immunoprecipitates were subjected to in vitro kinase assay using GST-c Jun (1 ± 79) as substrate. The phosphorylated proteins were resolved by SDS ± PAGE and visualized by autoradiography p21 waf1/cip1 expression remained unchanged for up to 120 min after addition of TNFa to the cells, while JNK dephosphorylation was complete after 60 min. Thus, p21 waf1/cip1 induction cannot account for the rapid inactivation of JNK that is observed in TNFa-treated EW7pc cells.
Prolonged TNFa-induced JNK activation in the presence of the super repressor of NF-kB is caspase-independent
We previously demonstrated that expression of the super repressor [IkBa(A32/36)] of NF-kB resulted in a drastic enhancement of the susceptibility of EW7 cells to TNFa-induced apoptosis. Others have reported that caspase activation during apoptosis may activate stress response pathways (Chen et al., 1996; Roulston et al., 1998) . Therefore, prolongation of JNK activation in EW7MAD1 cells might have been the consequence of caspase activation. In order to test this hypothesis, EW7MAD1 cells were pretreated with Z-VAD-FMK, a broad spectrum caspase inhibitor, prior to treatment with TNFa. JNK activation was measured after 0.5, 6 and 15 h of treatment with TNFa, and apoptosis was assessed by evaluating the percentage of cells carrying fragmented nuclei after 18 h of treatment. Whereas treatment of cells with 50 mM Z-VAD-FMK completely abolished TNFa-induced apoptosis (Figure 3a) , it had no eect on either the kinetics nor the extent of JNK activation (Figure 3b) . Thus, the prolongation of JNK activation in EW7MAD1 cells is not a consequence of apoptosis-associated caspase activation.
The kinetics of p38 activation by TNFa is identical in control and IkBa(A32/36)-expressing cells
Binding of TNFa to its receptors results in the activation of MAPKKKs which activate both the JNK and the p38 pathways (Ichijo, 1999) . Therefore, we asked whether NF-kB activation exerts an in¯uence on the kinetics of p38 activation similar to its action on JNK. Thus EW7pc and EW7MAD cells were treated with TNFa for dierent times, and p38 activation was determined by Western blot analysis using antibodies speci®c for the phosphorylated form of this kinase. As shown in Figure 4 , treatment of EW7pc, EW7MAD1 and EW7MAD2 cells with TNFa resulted in a stimulation of p38 phosphorylation which remained sustained in the three cell lines. Therefore we conclude that p38 activation is insensitive to NF-kB and that downregulation of JNK activation occurs at a step which lies downstream of MAPKKK activation.
Expression of MKP-1 is independent on NF-kB activation
It is known that protein phosphatases play a crucial role in controlling MAP kinase activity (Keyse, 2000) . Thus, the sustained activation of JNK induced by TNFa in the presence of the inhibitor of NF-kB activation might be the consequence of an inhibition of the expression of a phosphatase that speci®cally inactivates JNK. We focused on MKP1 since this phosphatase has been shown to inactivate JNK in vitro and in vivo, and since its synthesis is inducible by TNFa (Guo et al., 1998 ). We investigated whether the level of MKP-1 induction by TNFa was reduced in EW7MAD cells as compared to control EW7pc cells. As shown in Figure  5 , a rapid induction of the expression of a 40 kDa protein, similar in molecular mass to MKP-1, occurred . The blots were also probed with an antibody to actin as a control for protein loading equivalence Correlation between a sustained activation of JNK and cell death Since in several cellular systems JNK is pro-apoptotic only if its activation is sustained (Chen et al., 1996; Guo et al., 1998; Sanchez-Perez et al., 1998) , we asked whether the rapid repression of JNK activation by NFkB participates in the anti-apoptotic eect of this transcription factor. Therefore, the eects of a sustained versus a transient activation of JNK on the viability of EW7pc cells were compared. In order to prolong TNFa-induced JNK activation, EW7pc cells were pretreated with vanadate, which inhibits protein phosphatases. The kinetics of JNK activation were analysed and the consequence of these treatments on cell viability was determined. As shown in Figure 6a and 6b, a 2 h pretreatment of cells with vanadate greatly prolonged the duration of TNFa-induced JNK activation. Such pretreatment with vanadate rendered the cells susceptible to TNFa-induced cell death (Figure 6f) . By itself vanadate induced only a transient Figure 4 Kinetics of p38 activation by TNFa in the presence or in the absence of the super repressor of NF-kB. EW7pc, EW7MAD1 or EW7MAD2 cells were treated with TNFa for indicated times followed by cell lysis. Equal amounts of proteins were analysed by Western blot using polyclonal anti-phospho-p38 or anti-p38 antibodies Figure 5 Eect of TNFa on MKP-1 expression in the presence or the absence of the super repressor of NF-kB. EW7pc, EW7MAD1 and EW7 MAD2 cells were treated with TNFa for indicated times followed by cell lysis. Equal amounts of proteins were analysed by Western blot using anti-MKP-1 antibodies. The blots were also probed with an antibody to actin as a control for protein loading equivalence (Figure 6c ) which did not result in apoptosis (Figure 6f ). In contrast when vanadate was kept in the culture medium, it induced concentrationdependent JNK activation (Figure 6d ) which remained sustained for at least 15 h ( Figure 6e ) and was associated with the presence of 25% of apoptotic cells (Figure 6f ). Prolonged activation of JNK and induction of apoptosis required similar concentrations of vanadate (Figure 6d and 6f) . Thus, indeed, a correlation exists between sustained JNK activation and induction of apoptosis.
Inhibition of TNFa-induced apoptosis by overexpression of a dominant negative form of JNK1
To demonstrate that JNK activation participates in induction of apoptosis in TNFa-treated EW7MAD cells, we transiently transfected these cells with an empty pcDNA vector or a vector encoding a mutant JNK1. This mutant is an inactive enzyme mutated at Thr183 and Tyr185 which acts as a dominant negative form of JNK1. Both vectors each were added together with a construct encoding the Green Fluorescent Protein (GFP) to allow for the identi®cation of transfected cells. Subsequently, cells were either left untreated or were treated with TNFa for 18 h. Nuclear fragmentation was evaluated by Hoechst staining, and the percentage of apoptotic cells in the population of transfected cells (GFP positive) was determined. As shown in Figure 7 , overexpression of mutant JNK1 reduced apoptosis in TNFa-treated EW7MAD1 and EW7MAD2 cells. Altogether, our results support the conclusions that prolonged JNK activation, indeed, is an apoptotic signal in EW7 cells.
Discussion
Apoptosis is a tightly controlled process essential for the precise regulation of development, homeostasis and elimination of damaged or pathogenic cells. Defects in the processes controlling apoptosis can contribute to carcinogenesis by extending the life span of cells, promoting resistance to immune destruction, permitting growth factor-independent survival, or conferring resistance to anticancer drugs and radiations (Reed, 1999) . Activation of the transcription factor NF-kB decreases the susceptibility of many cell types to apoptotic stimuli and thus contributes to neoplasic cell expansion (Barkett and Gilmore, 1999; Mayo and Baldwin, 2000) . An understanding of the mechanisms implicated in the control of apoptosis by NF-kB may thus lead to the development of new strategies to improve cancer therapy. Although several genes that may play a role in blocking apoptosis and whose expression is regulated by NF-kB have been identi®ed, the precise understanding of the role of NF-kB in controlling apoptosis is still lacking (Barkett and Gilmore, 1999; Aggarwal, 2000) . We previously reported that Ewing sarcoma cells which are resistant to TNFa-induced apoptosis, can be made susceptible to the apoptotic eect of this cytokine when transfected with a vector encoding a super repressor of NF-kB activation (Javelaud et al., 2000) .
In this study we demonstrate a novel eect of NF-kB activation that participates in the anti-apoptotic eect of this transcription factor. We show that activation of NF-kB interferes with activation of the JNK pathway in TNFa-treated Ewing sarcoma cells. In cells carrying a super repressor of NF-kB activation, TNFa induced a prolonged JNK activation whereas this activation was transient in control cells. Sustained JNK phosphorylation was not a consequence of apoptosisassociated caspase activation, since it was still observed in EW7MAD cells treated with TNFa in the presence of the caspase inhibitor Z-VAD-FMK, under conditions where this compound completely inhibited apoptosis. Although control cells were totally resistant to the cytotoxic eect of TNFa, pretreatment of these cells with the phosphatase inhibitor vanadate dramatically prolonged JNK activation by TNFa and resulted in induction of apoptosis by this cytokine. Moreover, expression of a dominant negative mutant of JNK1 reduced TNFa-induced apoptosis in cells carrying the super repressor of NF-kB activation. Altogether, our results indicate that, in the absence of NF-kB activation, the sustained activation of JNK participates in death signaling triggered by TNFa.
We previously identi®ed the cyclin-dependent kinase inhibitor p21 waf1/cip1 as an anti-apoptotic protein induced by TNFa, and demonstrated that its induction required NF-kB activity (Javelaud et al., 2000) . An inhibitory eect of p21 waf1/cip1 on JNK activation has been described (Shim et al., 1996; Patel et al., 1998; Asada et al., 1999) . However, induction of p21 waf1/cip1 by TNFa 
of three independent experiments
Oncogene NF-kB represses TNFa-induced JNK activation D Javelaud and F Besanc Ë on in control cells was not responsible for the lability of JNK activation, since the time course of its induction did not correlate with that of JNK dephosphorylation. The activity of MAPK re¯ects a balance between the activities of the upstream kinases and protein phosphatases (Keyse, 2000) . Among the phosphatases which can dephosphorylate JNK, MKP-1 is a nuclear dual speci®city (threonine/tyrosine) phosphatase which is inducible by mitogenic signals and TNFa (Sun et al., 1993; Guo et al., 1998) . However, a dierence in MKP-1 induction could not account for the dierence in kinetics of JNK activation in control cells as compared to cells carrying the super repressor of NF-kB. In fact, TNFa-treatment of cells expressing this super repressor caused an even higher MKP-1 expression than treatment of corresponding control cells, which is in accordance with the previous demonstration of a positive regulation of MKP-1 expression by the JNK signaling pathway (Bokemeyer et al., 1996) . Our results suggest that in Ewing sarcoma cells MKP-1 is not the major phosphatase that controls JNK phosphorylation. Thus the role of NF-kB may be to either induce another JNK speci®c phosphatase, or to inhibit an activating signal which is speci®c for the JNK pathway. Activation of MAPKKKs by TNFa stimulates both the JNK and p38 pathways which diverge at the level of MAPKKs (Ichijo, 1999) . Therefore this NF-kB sensitive signal should be downstream of MAPKKKs activation, since we observed that kinetics of p38 activation by TNF-a were identical in both control EW7pc cells and IkBa(A32/36)-carrying cells.
An obligatory role of the JNK pathway has clearly been demonstrated in various stress-induced apoptosis models. However, its implication in other cellular systems including TNFa-induced apoptosis remains controversial (LeppaÈ and Bohmann, 1999) . JNK kinases can be activated by inducers of apoptosis such as environmental stresses or death receptor ligation, but also by mitogenic signals including growth factors, oncogenic Ras, CD40 ligation and T-cell activation signaling. In fact, it emerges from several reports that the duration of JNK activation is a crucial factor in determining the cellular response. For example, in Jurkat cells, the transient activation of JNK leads to cell proliferation or dierentiation, and prolonged JNK activation causes apoptosis. Moreover, co-treatment of these cells with T-cell activation signals and a phosphatase inhibitor extended the duration of JNK activation and caused apoptosis (Chen et al., 1996) . Also, strong and prolonged activation of JNK has been reported in response to lethal doses of a variety of stresses including UVC, g radiation and cisplatin (Chen et al., 1996; Sanchez-Perez et al., 1998) , any one of which triggers apoptosis. Similarly, in dierentiated neuronal PC-12 cells, JNK activity was persistently activated during apoptosis induced by nerve growth factor withdrawal (Xia et al., 1995) . Investigation of JNK activation under conditions where rat mesangial cells were either resistant or susceptible to TNFainduced apoptosis also revealed a correlation between a sustained JNK activation and initiation of apoptosis (Guo et al., 1998) . These results, together with our ®ndings, strongly support the hypothesis that the duration of JNK activation is the determining factor in the cell fate, and that only a sustained activation promotes apoptosis. Furthermore, these observations strongly suggest that the rapid inactivation of JNK which occurs in TNFa-treated Ewing sarcoma cells constitutes a mechanism by which NF-kB exerts its anti-apoptotic eect (Figure 8) . Identi®cation of such survival mechanisms should lead to the design of new strategies that could eectively enhance the therapeutic potential of TNFa in cancer treatment.
Materials and methods

Plasmids and reagents
The plasmid encoding the super repressor of NF-kB, IkBa (A32/36), was described by Traenckner et al. (1995) and was obtained from M Korner (CNRS UPR 9079, Villejuif, France). The pcDNA vector encoding the dominant-negative mutant of JNK1, (Ala and Phe substituted at Thr183 and Tyr185, respectively), has been previously described . The pEGFP vector encoding for the green uorescent protein was from Clontech. Recombinant human TNFa (speci®c activity: 5610 7 U/ mg) was purchased from Bender Wien and was used at a concentration of 1000 U/ml. Z-VAD-FMK was from Biomol and sodium orthovanadate (vanadate) from Sigma. Poly- Figure 8 Model for the anti-apoptotic eect of NF-kB in Ewing sarcoma cells: Binding of TNFa to its receptors generates both death and life signals. Activation of NF-kB induces a rapid repression of JNK activation that contributes to inhibition of TNFa-induced apoptosis clonal anti-phospho-JNK, anti-phospho-p38 and anti-p38 antibodies were from New England Biolabs. Anti-JNK1 and anti-MKP1 antibodies were from Santa Cruz, anti-actin and anti-p21 waf1/cip1 antibodies were from ICN and Transduction Laboratories, respectively. GST-c-jun (1-79) was purchased from Stratagene.
Cell lines and culture
EW7 cells stably transfected with the empty pcDNA vector (EW7pc cells) or with the IkBa (A32/36)-encoding vector (EW7MAD1 and EW7MAD2 cells) were obtained by electroporation (960 mF, 210 V) of 2610 7 cells with 10 mg of plasmid. These stable transfectants, selected and maintained in the presence of geneticin (1 mg/ml) have been previously described (Javelaud et al., 2000) .
All cells were propagated in RPMI medium supplemented with 2 mM L-glutamine and 10% fetal calf serum in collagencoated culture¯asks.
Western blot analysis
Cellular extracts were prepared in 10 mM Tris pH 7.4, 1% SDS, 1 mM sodium vanadate, treated with Benzon nuclease for 5 min at room temperature and boiled for 3 min. Fifty micrograms of proteins were loaded on an SDS-polyacrylamide gel. After electrophoresis, proteins were electrotransferred onto a nitrocellulose membrane. Membranes were blocked with 5% non-fat milk, 0.1% Tween-20 and probed with primary antibodies according to the manufacturer's instructions. The primary antibodies were labeled with horseradish peroxydase-conjugated secondary antibodies, which were then visualized using an enhanced chemiluminescence kit obtained from Amersham. The experiments were repeated three times and representative autoradiograms are shown.
JNK1 in vitro assay
JNK kinase activity was measured by immunocomplex kinase assay as previously described with minor modi®cations. Cells were washed twice with ice-cold phosphate-buered saline and lysed at 48C in a buer containing 10 mM Tris (pH 7.4), 150 mM NaCl, 10% glycerol, 1 mM EDTA, 1 mM EGTA, 0.5% Triton X-100, 0.5% NP-40, 0.5 mM sodium vanadate, 0.2 mM PMSF, 20 mg/ml aprotinin and 20 mg/ml leupeptin. Lysates were clari®ed by centrifugation and JNK1 was immunoprecipitated with a polyclonal goat anti-JNK1 antibody for 30 min at 48C. Immune complexes were collected on Sepharosecoupled protein G for 1 h at 48C, washed three times in lysis buer and once in kinase buer consisting of 12.5 mM MOPS (pH 7.5), 12.5 mM b-glycerophosphate, 7.5 mM MgCl 2 , 0.5 mM EGTA, 0.5 mM sodium¯uoride and 0.5 mM sodium vanadate. The immunoprecipitates were then resuspended in 30 ml of kinase buer containing as ®nal concentration, 2 mg of GST-c-Jun, 20 mM unlabeled ATP and 5 mCi of (g-32 P)ATP. After incubation at 308C for 20 min, the reaction was terminated by adding SDS sample buer followed by heating at 1008C for 5 min. The reaction products were analysed by 12% SDS ± PAGE and autoradiography.
Transfections and apoptosis assay
EW7pc or EW7MAD cells were transfected with either 10 mg of the empty pcDNA3 vector or the vector encoding for mutant JNK1 together with 2 mg of a construct encoding the Green Fluorescent Protein (GFP), allowing for the identi®ca-tion of transfected cells. To detect apoptosis in situ, cells were ®xed with 4% paraformaldehyde for 15 min, washed with PBS and stained with Hoechst 33258¯uorescent dye. The percentage of apoptotic cells was determined by counting the number of cells with fragmented nuclei in the population of transfected cells. An average of 300 cells were examined in each experiment.
